Hypothalamic obesity in patients with craniopharyngioma: Profound changes of several weight regulatory circuits

Frontiers in Endocrinology

Volumn 2, Issue OCT, 2011, Pages

  Roth, Christian L ^a  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

Author keywords

Autonomous nervous; Gut hormones; Hyperphagia; Hypothalamic lesion; Morbid obesity; Neuropeptides

Indexed keywords

EID: 84872173470     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2011.00049     Document Type: Review

References (68)

1. Abbott, C. R., Monteiro, M., Small, C. J., Sajedi, A., Smith, K. L., Parkinson, J. R., Ghatei, M. A., and Bloom, S. R. (2005). The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res. 1044, 127-131.
2. Ahmet, A., Blaser, S., Stephens, D., Guger, S., Rutkas, J. T., and Hamilton, J. (2006). Weight gain in craniopharyngioma-a model for hypothalamic obesity. J. Pediatr. Endocrinol. Metab. 19, 121-127.
3. Bai, F. L., Yamano, M., Shiotani, Y., Emson, P. C., Smith, A. D., Powell, J. F., and Tohyama, M. (1985). An arcuato-paraventricular and-dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat. Brain Res. 331, 172-175.
4. Bailey, C. J. (2005). Drugs on the horizon for diabesity. Curr.Diab.Rep.5, 353-359.
5. Balbo, S. L., Bonfleur, M. L., Carneiro, E. M., Amaral, M. E., Filiputti, E., and Mathias, P. C. (2002). Parasym-pathetic activity changes insulin response to glucose and neurotrans-mitters. Diabetes Metab. 28, 3S13-3S17; discussion 3S108-3S112.
6. Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., Cone, R. D., and Bloom, S. R. (2002). Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418, 650-654.
7. Berthoud, H. R., and Morrison, C. (2008). The brain, appetite, and obesity. Annu.Rev.Psychol.59, 55-92.
8. Bi, S. (2007). Role of dorsomedial hypothalamic neuropeptide Y in energy homeostasis. Peptides 28, 352-356.
9. Blevins, J. E., Morton, G. J., Williams, D. L., Caldwell, D. W., Bastian, L. S., Wisse, B. E., Schwartz, M. W., and Baskin, D. G. (2009). Forebrain melanocortin signaling enhances the hindbrain satiety response to CCK-8. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, R476-R484.
10. Blundell, J. E. (1982). Neuroregulators and feeding: implications for the pharmacological manipulation of hunger and appetite. Rev. Pure Appl. Pharmacol. Sci. 3, 381-462.
11. Blundell, J. E. (1990). Appetite disturbance and the problems of overweight. Drugs 39(SUPPL. 3), 1-19.
12. Brauner, R., Malandry, F., Rappaport, R., Pierre-Kahn, A., and Hirsch, J. F. (1987). Craniopharyngioma in children. Endocrine evaluation and treatment.Apropos of 37 cases. Arch. Fr. Pediatr. 44, 765-769.
13. Bray, G. A., and Nishizawa, Y. (1978). Ventromedial hypothalamus modulates fat mobilisation during fasting. Nature 274, 900-902.
14. Brobeck, J. R., Tepperman, J., and Long, C. N. H. (1943). Experimental hypothalamic hyperphagia in the albino rat. Yale J. Biol. Med. 15, 831-853.
15. Choi, S., Sparks, R., Clay, M., and Dallman, M. F. (1999). Rats with hypothalamic obesity are insensitive to central leptin injections. Endocrinology 140, 4426-4433.
16. Cota, D., Proulx, K., Smith, K. A., Kozma, S. C., Thomas, G., Woods, S. C., and Seeley, R. J. (2006). Hypothalamic mTOR signaling regulates food intake. Science 312, 927-930.
17. Curtis, J., Daneman, D., Hoffman, H. J., and Ehrlich, R. M. (1994). The endocrine outcome after surgical removal of craniopharyngiomas. Pediatr. Neurosurg. 21(Suppl. 1), 24-27.
18. Daousi, C., Dunn, A. J., Foy, P. M., MacFarlane, I. A., and Pinkney, J. H. (2005). Endocrine and neuroanatomic features associated with weight gain and obesity in adult patients with hypothalamic damage. Am.J.Med.118, 45-50.
19. Dawson, R. Jr., Wallace, D. R., and Gabriel, S. M. (1989). A pharmacological analysis of food intake regulation in rats treated neonatally with monosodium L-glutamate (MSG). Pharmacol. Biochem. Behav. 32, 391-398.
20. de Souza, C. T., Nunes, W. M., Gobatto, C. A., and de Mello, M. A. (2003). Insulin secretion in monosodium glutamate (MSG) obese rats submitted to aerobic exercise training. Physiol. Chem. Phys. Med. NMR 35, 43-53.
21. Defronzo, R. A., Ratner, R. E., Han, J., Kim, D. D., Fineman, M. S., and Baron, A. D. (2005). Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care 28, 1092-1100.
22. DeVile, C. J., Grant, D. B., Kendall, B. E., Neville, B. G., Stanhope, R., Watkins, K. E., and Hayward, R. D. (1996). Management of childhood cranio-pharyngioma: can the morbidity of radical surgery be predicted? J. Neurosurg. 85, 73-81.
23. Elfers, C., Ralston, M., and Roth, C. L. (2011). Studies of different female rat models of hypothalamic obesity. J. Pediatr. Endocrinol. Metab. 24, 131-137.
24. Figlewicz, D. P. (2003). Insulin, food intake, and reward. Semin. Clin. Neuropsychiatry 8, 82-93.
25. Figlewicz,D. P.,and Benoit,S. C. (2009). Insulin, leptin, and food reward: update 2008. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296, R9-R19.
26. Figlewicz, D. P., MacDonald Naleid, A., and Sipols, A. J. (2007). Modulation of food reward by adiposity signals. Physiol. Behav. 91, 473-478.
27. Galatzer, A., Nofar, E., Beit-Halachmi, N., Aran, O., Shalit, M., Roitman, A., and Laron, Z. (1981). Intellectual and psychosocial functions of children, adolescents and young adults before and after operation for craniopharyngioma. Child Care Health Dev. 7, 307-316.
28. Gardner, P. A., Kassam, A. B., Snyder-Man, C. H., Carrau, R. L., Mintz, A. H., Grahovac, S., and Stefko, S. (2008). Outcomes following endoscopic, expanded endonasal resection of suprasellar craniopharyn-giomas: a case series. J. Neurosurg. 109, 6-16.
29. Glavas, M. M., Joachim, S. E., Draper, S. J., Smith, M. S., and Grove, K. L. (2007). Melanocortinergic activation by melanotan II inhibits feeding and increases uncoupling protein 1 messenger ribonucleic acid in the developing rat. Endocrinology 148, 3279-3287.
30. Harz, K. J., Muller, H. L., Waldeck, E., Pudel, V., and Roth, C. (2003). Obesity in patients with craniopharyn-gioma: assessment of food intake and movement counts indicating physical activity. J. Clin. Endocrinol. Metab. 88, 5227-5231.
31. Imura, H., Kato,Y., and Nakai,Y. (1987). Endocrine aspects of tumors arising from suprasellar, third ventricular regions. Prog. Exp. Tumor Res. 30, 313-324.
32. Inge, T. H., Pfluger, P., Zeller, M., Rose, S. R., Burget, L., Sundarara-Jan, S., Daniels, S. R., and Tschop, M. H. (2007). Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy. Nat. Clin. Pract. Endocrinol. Metab. 3, 606-609.
33. Kerkerian, L., and Pelletier, G. (1986). Effects of monosodium L-glutamate administration on neuropeptide Y-containing neurons in the rat hypothalamus. Brain Res. 369, 388-390.
34. Kubota, A., Nakagawa, Y., and Igarashi, Y. (1994). Studies of gene expression in liver of insulin-like growth factor (IGF)-I, IGF binding protein-3 and growth hormone (GH) receptor/GH binding protein in rats treated neonatally with monosodium glutamate. Horm. Metab. Res. 26, 497-503.
35. Leitner, C., and Bartness, T. J. (2008). Food deprivation-induced changes in body fat mobilization after neonatal monosodium glutamate treatment. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R775-R783.
36. Lin, H. C., Neevel, C., Chen, P. S., Suh, G., and Chen, J. H. (2003). Slowing of intestinal transit by fat or pep-tide YY depends on beta-adrenergic pathway. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G1310-G1316.
37. Lustig, R. H., Post, S. R., SrivannaBoon, K., Rose, S. R., Danish, R. K., Burghen, G. A., Xiong, X., Wu, S., and Merchant, T. E. (2003). Risk factors for the development of obesity in children surviving brain tumors. J. Clin. Endocrinol. Metab. 88, 611-616.
38. Lustig, R. H., Tsai, P., Hirose, S., and Farmer, D. L. (2009). "Treatment of hypothalamic obesity by laparoscopic truncal vagatomy: early experience," in Abstract LWPES/ESPE 8th Joint Meeting Paediatric Endocrinology, Hormone Research 2009, New York, 72, S3:48.
39. Morton, G. J., Cummings, D. E., Baskin, D. G., Barsh, G. S., and Schwartz, M. W. (2006). Central nervous system control of food intake and body weight. Nature 443, 289-295.
40. Muller,H. L. (2006). More or less? Treatment strategies in childhood cranio-pharyngioma. Childs Nerv. Syst. 22, 156-157.
41. Muller, H. L. (2008). Childhood cran-iopharyngioma. Recent advances in diagnosis, treatment and follow-up. Horm. Res. 69, 193-202.
42. Muller, H. L., Bueb, K., Bartels, U., Roth, C.,Harz,K.,Graf,N.,Korinthenberg, R., Bettendorf, M., Kuhl, J., Gut-Jahr, P., Sorensen, N., and Calaminus, G. (2001). Obesity after childhood craniopharyngioma-German multicenter study on preoperative risk factors and quality of life. Clin. Padiatr. 213, 244-249.
43. Muller, H. L., Emser, A., Faldum, A., Bruhnken, G., Etavard-Gorris, N., Gebhardt, U., Oeverink, R., Kolb, R., and Sorensen, N. (2004). Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyn-gioma. J. Clin. Endocrinol. Metab. 89, 3298-3305.
44. Muller, H. L., Gebhardt, U., Wessel, V., Schroder, S., Kolb, R., Sorensen, N., Maroske, J., and Hanisch, E. (2007). First experiences with laparoscopic adjustable gastric banding (LAGB) in the treatment of patients with childhood craniopharyngioma and morbid obesity. Klin. Padiatr. 219, 323-325.
45. Parton, L. E., Ye, C. P., Coppari, R., Enriori, P. J., Choi, B., Zhang, C. Y., Xu, C., Vianna, C. R., Balthasar, N., Lee, C. E., Elmquist, J. K., Cowley, M. A., and Lowell, B. B. (2007). Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 449, 228-232.
46. Pascual, J. M., Carrasco, R., Prieto, R., Gonzalez-Llanos, F., Alvarez, F., and Roda, J. M. (2008). Cranio-pharyngioma classification. J. Neurosurg. 109, 1180-1182; author reply 1182-1183.
47. Perello, M., Moreno, G., Gaillard, R. C., and Spinedi, E. (2004). Glucocorticoid-dependency of increased adiposity in a model of hypothalamic obesity. Neuro Endocrinol. Lett. 25, 119-126.
48. Petrovich, G. D., Setlow, B., Holland, P. C., and Gallagher, M. (2002). Amygdalo-hypothalamic circuit allows learned cues to override satiety and promote eating. J. Neurosci. 22, 8748-8753.
49. Poon, T. K., and Cameron, D. P. (1978). Measurement of oxygen consumption and locomotor activity in monosodium glutamate-induced obesity. Am. J. Physiol. 234, E532-E534.
50. Roth, C. L., Aylward, E., Liang, O., Pauley, G., Kleinhans, N. M., and Schur, E. (2011a). Functional neuroimaging in cranio-pharyngioma: useful tool to better understand hypothalamic obesity? Abstract Annual Meeting The Endocrine Society, Boston.
51. Roth, C. L., Blevins, J. E., Ralston, M., Elfers, C., Ogimoto, K., Kaiyala, K. J., and Morton, G. J. (2011b). A novel rodent model that mimics the metabolic sequelae of obese cranio-pharyngioma patients. Pediatr. Res. 69, 230-236.
52. Roth, C. L., Gebhardt, U., and Muller, H. L. (2011c). Appetite-regulating hormone changes in patients with craniopharyngioma. Obesity (Silver Spring) 19, 36-42.
53. Roth, C. L., Enriori, P. J., Gebhardt, U., Hinney, A., Muller, H. L., Hebebrand, J., Reinehr, T., and Cowley, M. A. (2010). Changes of peripheral alpha-melanocyte-stimulating hormone in childhood obesity. Metab. Clin. Exp. 59, 186-194.
54. Roth, C. L., Hunneman, D. H., Gebhardt, U., Stoffel-Wagner, B., Reinehr, T., and Muller, H. L. (2007). Reduced sympathetic metabolites in urine of obese patients with cran-iopharyngioma. Pediatr. Res. 61, 496-501.
55. Roth, C. L., Wilken, B., Hanefeld, F., Schroter, W., and Leonhardt, U. (1998). Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. Eur. J. Endocrinol. 138, 89-91.
56. Sahu, A., Kalra, S. P., Crowley, W. R., and Kalra, P. S. (1988). Evidence that NPY-containing neurons in the brainstem project into selected hypothalamic nuclei: implication in feeding behavior. Brain Res. 457, 376-378.
57. Sawchenko, P. E., Swanson, L. W., Grzanna, R., Howe, P. R., Bloom, S. R., and Polak, J. M. (1985). Colocalization of neuropeptide Y immunoreactivity in brainstem cat-echolaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J. Comp. Neurol. 241, 138-153.
58. Schoelch, C., Hubschle, T., Schmidt, I., and Nuesslein-Hildesheim, B. (2002). MSG lesions decrease body mass of suckling-age rats by attenuating circadian decreases of energy expenditure. Am. J. Physiol. Endocrinol. Metab. 283, E604-E611.
59. Schwartz, M. W. (2006). Central nervous system regulation of food intake. Obesity (Silver Spring) 14(Suppl. 1), 1S-8S.
60. Schwartz, M. W., and Gelling, R. W. (2002). Rats lighten up with MCH antagonist. Nat. Med. 8, 779-781.
61. Schwartz, M. W., Woods, S. C., Porte, D. Jr., Seeley, R. J., and Baskin, D. G. (2000). Central nervous system control of food intake. Nature 404, 661-671.
62. Small, C. J., Parkinson, J. R., and Bloom, S. R. (2005). Novel therapeutic targets for appetite regulation. Curr. Opin. Investig. Drugs 6, 369-372.
63. Sorva, R. (1988). Children with cran-iopharyngioma. Early growth failure and rapid postoperative weight gain. Acta Paediatr. Scand. 77, 587-592.
64. Stellar, E. (1954). The physiology of motivation. Psychol. Rev. 61, 5-22.
65. Tokunaga, K., Bray, G. A., and Matsuzawa, Y. (1993). Improved yield of obese rats using a double coordinate system to locate the ventromedial or paraventricular nucleus. Brain Res. Bull. 32, 191-194.
66. Tokunaga, K., Matsuzawa, Y., Fujioka, S., Kobatake, T., Keno, Y., Odaka, H., Matsuo, T., and Tarui, S. (1991). PVN-lesioned obese rats maintain ambulatory activity and its circadian rhythm. Brain Res. Bull. 26, 393-396.
67. Vinchon, M., Weill, J., Delestret, I., and Dhellemmes, P. (2009). Craniopharyngioma and hypothalamic obesity in children. Childs Nerv. Syst. 25, 347-352.
68. Wynne, K., Stanley, S., McGowan, B., and Bloom, S. (2005). Appetite control. J. Endocrinol. 184, 291-318.